Gastroenterologist pay has risen 11 percent in the last year, reaching $501,000 annually and outpacing the average specialty physician pay by $119,000. This jump in pay comes as high inflation rates continue to threaten practices, and a new Doximity report shows that many physician salaries are not keeping pace with inflation. Neal Kaushal, MD, a gastroenterologist at Adventist Health in Sonora, Calif., told Becker’s that while inflation is rising nationwide, he does not believe that is the main contributor to growing gastroenterology salaries. Instead, he believes that as the demand for gastroenterologists drives competition for talent among hospitals, ASCs and…
Author: Abhay Panchal
Burnout rates among physicians have been on the rise since 2021, with only 57.5 percent of physicians indicating they would choose the profession again, according to a 2022 survey of 2,500 U.S. physicians conducted by researchers at the American Medical Association, Rochester, Minn.-based Mayo Clinic, Stanford (Calif.) University School of Medicine and the University of Colorado School of Medicine in Aurora. That number was down from 72.2 percent in 2020. Additionally, physician professional fulfillment scores dropped from 40 percent in 2020 to 22.4 percent in 2021. With physician burnout rates at an all-time high, here are six ways for leaders…
Abstract: Private equity (PE) investment in gastroenterology practices has significantly increased over the past several years. Because PE firms are prevented legally from owning a medical practice in many states, they usually form a management services organization to oversee all nonclinical aspects of the practice, leaving all clinical functions to the physician owners. Gastroenterology practices have become attractive investments to PE firms because of the willingness of gastroenterologists to join a PE-backed practice and the potential to earn profits through consolidating the market. Research has started to examine the effects of PE-backed practices on patients and on the gastroenterology specialty…
DENVER–(BUSINESS WIRE)–Gastro Care Partners (“GCP”), one of the largest providers of gastroenterology services and ancillary patient treatment services in Colorado and Wyoming, today announced that David Pyle has joined the company as Chief Executive Officer. As CEO, Mr. Pyle will continue to support GCP’s growth trajectory and expand its footprint through the continued development of ambulatory surgery centers, the introduction of new, value-added ancillary service lines, the expansion of partnerships with key hospitals and health systems, and the execution of accretive M&A opportunities with like-minded, growth-oriented physician shareholders. Mr. Pyle comes to GCP with significant experience in healthcare services and…
In a recent study published in JAMA Internal Medicine, researchers evaluated the ability of ChatGPT, an artificial intelligence-based chatbot assistant, to respond to patient questions posted on a publically accessible social media forum. Background:Owing to the quick expansion of digital health care, more and more patients have begun to raise queries on social media forums. Answering these questions is not just time-consuming but tedious for healthcare professionals. AI assistants, like ChatGPT, could help address this additional work and help draft quality responses, which later clinicians could review. read More
Olympus today announced it received FDA clearance for its new Evis X1 endoscopy system and two compatible gastrointestinal endoscopes. The FDA clearance covers Olympus’ GIF-1100 gastrointestinal videoscope indicated for use in the upper digestive tract, and the CF-HQ1100DL/I colonovideoscope indicated for use in the lower digestive tract. Olympus’s GI endoscopy systems are used by physicians to help diagnose, treat and observe diseases and disorders of the upper and lower GI tract, such as acid reflux, ulcers, Crohn’s disease, Celiac disease and colorectal cancer. According to the company, one of the most common uses of an endoscope is for screening colonoscopy,…
In one of the largest healthcare deals to date, Kaiser Permanente is acquiring Pennsylvania-based Geisinger Health and investing $5 billion to fold it into a new nonprofit subsidiary called Risant Health, which is set to purchase additional medical groups in coming years. While regulators still must review this initial acquisition, the marriage of Kaiser and Geisinger would create a behemoth with more than $100 billion in annual revenue — 95% of it coming from the Kaiser side of the equation. Like Kaiser, Geisinger both owns hospitals — 10 of them — and operates its own health insurance program. Unlike California-based…
This article reviews current bowel prep options, safety considerations, and best practice recommendations. Recommendations include additional fluids for low-volume preps, specific dosage timing, low-residue diet for part of the day prior to colonoscopy, use of online pharmacies and discount coupons to improve access to low-volume preps, and clinical support tools and navigation to improve compliance. Read More
MedicalResearch.com: What is the background for this study? Would you describe the ReCET procedure? Response: Currently more than 400 million people worldwide have type 2 diabetes (T2D) and these numbers are rapidly increasing. At the moment there is no treatment option available that effectively treats the root cause of T2D, i.e. insulin resistance, the increasing loss of response to our body’s own insulin. T2D is generally treated with drug therapy, yet drug therapy can be expensive, requires the patient to take their drugs every day, and at best “controls” the disease without actually resolving it. Despite the availability of many…
Nonalcoholic fatty liver disease (NAFLD) results from fat accumulation within the liver and ranges from simple steatosis to steatohepatitis progressing to cirrhosis. NAFLD has become the most common cause of liver disease in the United States and Europe because of an aging population and increased prevalence of metabolic syndrome characterized by hypertension, hyperlipidemia, type 2 diabetes (T2DM), and central obesity.1 NAFLD is strongly associated with obesity and T2DM, where the prevalence of NAFLD in patients undergoing bariatric surgery exceeds 90% compared with an estimated prevalence of 25% in the general population.2 In patients with NAFLD, the estimated prevalence rates of…